Dynavax Technologies Corp
NASDAQ:DVAX
Dynavax Technologies Corp
NASDAQ:DVAX
Price:
11.5 USD
0.97%
Market Closed
Updated:
May 29, 2024
Dynavax Technologies Corp
Pre-Tax Income
|
Dynavax Technologies Corp
Pre-Tax Income Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dynavax Technologies Corp
NASDAQ:DVAX
|
Pre-Tax Income
$7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Pre-Tax Income
$7.5B
|
CAGR 3-Years
22%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Pre-Tax Income
$1.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-16%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Pre-Tax Income
$4.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Pre-Tax Income
$4.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Pre-Tax Income
$4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
18%
|
See Also
What is Dynavax Technologies Corp's Pre-Tax Income?
Pre-Tax Income
7.8m
USD
7.8m
USD
Based on the financial report for Mar 31, 2024, Dynavax Technologies Corp's Pre-Tax Income amounts to 7.8m USD.
What is Dynavax Technologies Corp's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 1Y
-97%
-97%
Over the last year, the Pre-Tax Income growth was -97%.
You don't have any saved screeners yet
